Li Zhou
- Cancer Research top 2%
- MicroRNA in disease regulation 27
- Immunology top 5%
- Immune Cell Function and Interaction 22
- Immunotherapy and Immune Responses 14
- T-cell and B-cell Immunology 12
- Molecular Biology top 5%
- Circular RNAs in diseases 8
- Extracellular vesicles in disease 7
- RNA Interference and Gene Delivery 6
- Rehabilitation top 5%
- Wound Healing and Treatments 7
- Nephrology top 5%
- Co-authors
- Qing‐Sheng MiMatthew WeilandXing-Hua GaoZheng DongAimin JiangChunmei FuQuanhui ZhengJin‐Xiong She
- Journals
- The Journal of Immunology (5 papers)Oncotarget (5 papers)Frontiers in Immunology (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Li Zhou
141 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 145
- Cancer Research 846
- Immunology 750
- Molecular Biology 1.3k
- Rehabilitation 127
- Nephrology 118
Countries citing papers authored by Li Zhou
This map shows the geographic impact of Li Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhou more than expected).
Fields of papers citing papers by Li Zhou
This network shows the impact of papers produced by Li Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhou. The network helps show where Li Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 28 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 20 | |
| 12 | 2022 | 18 | |
| 13 | 2021 | 18 | |
| 14 | 2021 | 33 | |
| 15 | 2015 | 68 | |
| 16 | Increased HDAC3 and decreased miRNA-130a expression in PBMCs through recruitment HDAC3 in patients with spinal cord injuries. | 2015 | 16 |
| 17 | 2014 | 1 | |
| 18 | 2011 | 26 | |
| 19 | 2007 | 2 | |
| 20 | Effects of Myocardial Fibroblasts on Fibrosis in Diabetic Cardiomyopathy | 2002 | 1 |
About Li Zhou
Li Zhou is a scholar working on Cancer Research, Immunology and Nephrology, having authored 152 papers that have together received 2.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (27 papers), Immune Cell Function and Interaction (22 papers), Immunotherapy and Immune Responses (14 papers), T-cell and B-cell Immunology (12 papers), Circular RNAs in diseases (8 papers), Wound Healing and Treatments (7 papers), Extracellular vesicles in disease (7 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Cancer Research (846 citations), Immunology (750 citations) and Molecular Biology (1.3k citations). Li Zhou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qing‐Sheng Mi, Matthew Weiland, Xing-Hua Gao, Zheng Dong, Aimin Jiang, Chunmei Fu, Quanhui Zheng, Jin‐Xiong She, Yi Yao and Calvin C. Sheng. Their work appears in journals such as The Journal of Immunology, Oncotarget, Frontiers in Immunology, Journal of Investigative Dermatology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.